Related Experiment Video
Updated: Apr 15, 2026
Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Dermatomyositis-Related Nonischemic Central Retinal Vein Occlusion
Yvonne Wang1, Michael L Morgan, Angelina Espino Barros Palau
1Weill Cornell Medical College Departments of Ophthalmology, Neurology, and Neurosurgery (YW, AGL), Weill Cornell Medical College, New York, New York; Department of Ophthalmology (MLM, AEBP, AGL), Houston Methodist Hospital, Houston, Texas; Weill Cornell Medical College Departments of Ophthalmology (AGL), Neurology, and Neurosurgery, Weill Cornell Medical College, Houston, Texas; Department of Ophthalmology (AGL, RF), Baylor College of Medicine, Houston, Texas; Department of Ophthalmology and Visual Sciences (AGL), The University of Texas Medical Branch, Galveston, Texas; and Department of Head & Neck Surgery (AGL), The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract:
A 25-year-old woman with dermatomyositis suffered a right central retinal vein occlusion (CRVO) with visual acuity of 20/40. Examination of the right eye showed vitreous cells, suggesting inflammation of the central retinal vein leading to a CRVO as the presumed mechanism. She was admitted to hospital, and extensive evaluation was negative. She was maintained on corticosteroids to manage her dermatomyositis. One month later, she had macular edema and elevated intraocular pressure. Both resolved with dorzolamide, timolol, and intravitreal bevacizumab, and vision returned to 20/20 in the right eye.
Related Concept Videos
01:25Glaucoma: Overview
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...